1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3.Global Active Pharmaceutical ingredient Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Global Active Pharmaceutical ingredient Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Global Active Pharmaceutical ingredient Market – Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porter's Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Global Active Pharmaceutical ingredient Market
10.1.Overview
10.2. Historical Analysis (2018-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Global Active Pharmaceutical ingredient Market Size & Forecast 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Type
11.3.1.1. Innovation API
11.3.1.1.1. By Value (USD Million) 2024A-2034F
11.3.1.1.2.Market Share (%) 2024A-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024A-2034F
11.3.1.2.Generic API
11.3.1.2.1.By Value (USD Million) 2024A-2034F
11.3.1.2.2. Market Share (%) 2024A-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.3.Others
11.3.1.3.1.By Value (USD Million) 2024A-2034F
11.3.1.3.2. Market Share (%) 2024A-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2. By Manufacturer
11.3.2.1.Captive API Manufacturer
11.3.2.1.1.By Value (USD Million) 2024A-2034F
11.3.2.1.2. Market Share (%) 2024A-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2.2. Merchant API Manufacturer
11.3.2.2.1. By Value (USD Million) 2024A-2034F
11.3.2.2.2.Market Share (%) 2024A-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2024A-2034F
11.3.2.3.2.Market Share (%) 2024A-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024A-2034F
11.3.3. By Synthesis
11.3.3.1.Synthetic APIs
11.3.3.1.1.By Value (USD Million) 2024A-2034F
11.3.3.1.2. Market Share (%) 2024A-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.3.2. Biotech APIs
11.3.3.2.1. By Value (USD Million) 2024A-2034F
11.3.3.2.2.Market Share (%) 2024A-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.4. Application
11.3.4.1.Cardiovascular Disease
11.3.4.1.1.By Value (USD Million) 2024A-2034F
11.3.4.1.2. Market Share (%) 2024A-2034F
11.3.4.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.4.2. Oncology
11.3.4.2.1. By Value (USD Million) 2024A-2034F
11.3.4.2.2.Market Share (%) 2024A-2034F
11.3.4.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.4.3. Neurological Disorders
11.3.4.3.1. By Value (USD Million) 2024A-2034F
11.3.4.3.2. Market Share (%) 2024A-2034F
11.3.4.3.3. Y-o-Y Growth (%) 2024A-2034F
11.3.4.4. Orthopedic Disorders
11.3.4.4.1.By Value (USD Million) 2024A-2034F
11.3.4.4.2. Market Share (%) 2024A-2034F
11.3.4.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.4.5. Respiratory
11.3.4.5.1.By Value (USD Million) 2024A-2034F
11.3.4.5.2. Market Share (%) 2024A-2034F
11.3.4.5.3. Y-o-Y Growth (%) 2024A-2034F
11.3.4.6. Urology
11.3.4.6.1. By Value (USD Million) 2024A-2034F
11.3.4.6.2.Market Share (%) 2024A-2034F
11.3.4.6.3.Y-o-Y Growth (%) 2024A-2034F
11.3.4.7. Others
11.3.4.7.1. By Value (USD Million) 2024A-2034F
11.3.4.7.2.Market Share (%) 2024A-2034F
11.3.4.7.3.Y-o-Y Growth (%) 2024A-2034F
12. North America Active Pharmaceutical ingredient Market Size & Forecast 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Type
12.3.2.By Manufacturer
12.3.3.By Synthesis
12.3.4.By Application
12.4. Country
12.4.1. United States
12.4.2.Canada
13. Europe Active Pharmaceutical ingredient Market Size & Forecast 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Type
13.3.2.By Manufacturer
13.3.3.By Synthesis
13.3.4.By Application
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia-Pacific Active Pharmaceutical ingredient Market Size & Forecast 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Type
14.3.2.By Manufacturer
14.3.3.By Synthesis
14.3.4. By Application
14.4. Country
14.4.1.India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Active Pharmaceutical ingredient Market Size & Forecast 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Type
15.3.2.By Manufacturer
15.3.3.By Synthesis
15.3.4.By Application
15.4. Country
15.4.1.Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa
16. Latin America Active Pharmaceutical ingredient Market Size & Forecast 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Type
16.3.2.By Manufacturer
16.3.3.By Synthesis
16.3.4.By Application
16.4. Country
16.4.1.Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1.Teva Pharmaceutical Industries Ltd.
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2.Key Clients
18.1.4.3.Market Share
18.1.4.4.Recent News & Development (Last 3 Yrs.)
18.2. Pfizer Inc.
18.3. Novartis International AG
18.4. Sanofi S.A.
18.5. Boehringer Ingelheim International GmbH
18.6. GlaxoSmithKline plc
18.7. Merck & Co., Inc.
18.8. AstraZeneca plc
18.9. Eli Lilly and Company
18.10. AbbVie Inc.
18.11.Cipla Inc.
18.12. Sun Pharmaceutical Industries Ltd.
18.13. Aurobindo Pharma Ltd.
18.14. Dr. Reddy's Laboratories Ltd.
18.15. Lonza Group AG
18.16. Other Prominent Players
19. Appendix
20.Consultant Recommendation